Investors
Newsroom

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
- Leadership Team
- Corporate Governance
Careers
- Job Openings

Investors
Newsroom

Lab technicians examining samples

Lab technicians examining samples

Latest News and Events

Home /

Newsroom

Filter by

Year Published
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011

Selections

February 2, 2016

Arrowhead to Webcast Fiscal 2016 First Quarter Results

Read More

January 19, 2016

Arrowhead’s ARC-AAT Granted EMA Orphan Drug Designation

Read More

January 7, 2016

Arrowhead Begins Dosing the Phase 2b MONARCH Combination Study of ARC-520 in Patients with Chronic Hepatitis B Infection

Read More

December 14, 2015

Arrowhead Reports Fiscal 2015 Year End Results

Read More

December 14, 2015

Arrowhead Added to NASDAQ Biotechnology Index®

Read More

December 7, 2015

Arrowhead to Webcast Fiscal 2015 Year End Results

Read More

December 7, 2015

Arrowhead’s ARC-520 Leads to Consistent Immune Reactivation in Chimpanzees with Chronic Hepatitis B Infection

Read More

November 16, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA

Read More

November 15, 2015

Arrowhead Presents Data Showing Robust Sustained Anti-viral Effects with ARC-520 in Hepatitis B Infected Chimpanzees

Read More

November 11, 2015

Arrowhead to Present at Upcoming Conferences

Read More

1...36 37 38 39 40...55

Footer Navigation

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
Careers

Facebook
Instagram
LinkedIn
Twitter

Privacy Policy
Cookie Policy
Terms of Use
Sitemap
Contact Us

© 2025 Arrowhead Pharmaceuticals, Inc.